Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
Comparison of Percutaneous Retrograsserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis: A Clinical Research Study Article.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Prothrombin and factor X are elevated in multiple sclerosis patients.
Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines.
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach.
Supramaximal Stimulus Intensity as a Diagnostic Tool in Chronic Demyelinating Neuropathy.
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Daclizumab (Zinbryta) for multiple sclerosis.
Ingested (oral) rituximab inhibits EAE.
Anterior disco-osteo-arterial conflict as a cause of intersegmental arterial flow impairment and spinal cord ischemia.
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis.
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Age-related changes in the function and structure of the peripheral sensory pathway in mice.
Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in João Pessoa, Paraíba, Brazil.
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.
Multi-Output Decision Trees for Lesion Segmentation in Multiple Sclerosis.
Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.
Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.
Autoimmune Myopathies: Where Do We Stand?
Pages
« first
‹ previous
…
715
716
717
718
719
720
721
722
723
…
next ›
last »